Kobayashi Pharmaceutical announces board and executive changes

** Kobayashi Pharmaceutical (TSE:4967) announced significant changes to its board of directors and executive team following the 107th Annual General Meeting of Shareholders held on March 28, 2025. In a strategic move aimed at reinforcing its commitment to quality and safety, the company elected Jinto Emi and Takeshi Mutsushima as new directors and Hiroshi Matsushima, Takeshi Kobayashi, Yoshiro Katae, Akio Takahashi, Masato Matsumoto, Misa Kusumoto and Toshiaki Kadokawa to the board.